{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:35:58Z","timestamp":1761154558222},"reference-count":30,"publisher":"Elsevier BV","issue":"11-12","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.vaccine.2003.10.016","type":"journal-article","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T13:04:02Z","timestamp":1069333442000},"page":"1498-1508","source":"Crossref","is-referenced-by-count":43,"title":["Immunization with heat-killed Mycobacterium bovis bacille Calmette\u2013Guerin (BCG) in Eurocine\u2122 L3 adjuvant protects against tuberculosis"],"prefix":"10.1016","volume":"22","author":[{"given":"M","family":"Haile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Hamasur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Pawlowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Jaxmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"K\u00e4llenius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.B","family":"Svenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.10.016_BIB1","unstructured":"Calmette A, La vaccination contre la tuberculose. Paris: Maison et Cie. p. 250."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB2","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis","volume":"22","author":"Rodriguez","year":"1993","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.271.9.698","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2003.10.016_BIB4","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.10.016_BIB5","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1016\/S0264-410X(00)00134-1","article-title":"Intranasal vaccination of mice against infection with Mycobacterium tuberculosis","volume":"28","author":"Falero-Diaz","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.10.016_BIB6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1365-2249.2001.01667.x","article-title":"Intranasal BCG vaccination protects BALB\/c mice against virulent Mycobacterium bovis and accelerates production of IFN-gamma in their lungs","volume":"126","author":"Lyadova","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB7","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1016\/S0264-410X(03)00274-3","article-title":"Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis","volume":"21","author":"Hamasur","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.10.016_BIB8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/IAI.65.2.623-629.1997","article-title":"Adjuvant modulation of immune responses to tuberculosis subunit vaccines","volume":"65","author":"Lindblad","year":"1997","journal-title":"Infect Immunol."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB9","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/S0264-410X(98)00408-3","article-title":"Nasal and parenteral immuniizations with diphtheria toxoid using monoglyceride\/fatty acid lipid suspensions as adjuvants","volume":"17","author":"Schr\u00f6der","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.10.016_BIB10","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/513642","article-title":"Disseminated bacille Calmette\u2013Guerin disease after vaccination: case report and review","volume":"24","author":"Talbot","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1365-2567.1998.00419.x","article-title":"Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype","volume":"93","author":"Medina","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2003.10.016_BIB12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0952-7915(95)80100-6","article-title":"Immunogenetics in the analysis of resistance to intracellular pathogens","volume":"7","author":"McLeod","year":"1995","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB13","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1128\/IAI.66.11.5268-5274.1998","article-title":"Acquired resistance but not innate resistance to Mycobacterium bovis bacillus Calmette-Gu\u00e9rin is compromised by interleukin-12 ablation","volume":"66","author":"Thompson-Snipes","year":"1998","journal-title":"Infect. Immunol."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB14","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1128\/IAI.60.7.2880-2886.1992","article-title":"Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice","volume":"60","author":"Huygen","year":"1992","journal-title":"Infect. Immunol."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB15","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.4049\/jimmunol.155.4.2057","article-title":"Dissection of strain difference in acquired protective immunity against Mycobacterium bovis Calmette\u2013Guerin bacillus (BCG): macrophages regulate the susceptibility through cytokine network and the induction of nitric oxide synthase","volume":"155","author":"Yoshida","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB16","doi-asserted-by":"crossref","first-page":"6946","DOI":"10.1128\/IAI.68.12.6946-6953.2000","article-title":"Genetically determined disparate innate and adaptive cell-mediated immune responses to pulmonary Mycobacterium bovis BCG infection in C57BL\/6 and BALB\/c mice","volume":"68","author":"Wakeham","year":"2000","journal-title":"Infect. Immunol."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB17","doi-asserted-by":"crossref","unstructured":"Weiss DW. Vaccination against tuberculosis with non-living vaccines. I. The problem and its historical background. Am Rev Respir Dis 1959;80:340\u2013358, 495\u2013509, 676\u2013688.","DOI":"10.1164\/arrd.1959.80.5.676"},{"key":"10.1016\/j.vaccine.2003.10.016_BIB18","unstructured":"Tuberculosis Program, Public Health Service, USA. Experimental studies of vaccination, allergy, and immunity in tuberculosis. 3. Effect of killed BCG vaccine. Bull WHO 1955;12:47\u201362."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4049\/jimmunol.138.1.293","article-title":"The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis","volume":"138","author":"Orme","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB20","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.4049\/jimmunol.154.7.3359","article-title":"Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice","volume":"154","author":"Andersen","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/eji.1830250211","article-title":"Immune response to Myocbacterium bovis bacille Calmette\u2013Guerin infection in major histocompatibility class I- and II-deficient knock-out mice contribution of CD4 and CD8 T cells to acquired resistance","volume":"24","author":"Ladel","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB22","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/infdis\/167.6.1481","article-title":"T cell response to Mycobacterium tuberculosis","volume":"167","author":"Orme","year":"1993","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB23","doi-asserted-by":"crossref","first-page":"12013","DOI":"10.1073\/pnas.89.24.12013","article-title":"Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection","volume":"89","author":"Flynn","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1073\/pnas.95.1.270","article-title":"Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis","volume":"95","author":"Lalvani","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1369-5274(99)80015-0","article-title":"T cell mediated immunity to Mycobacterium tuberculosis","volume":"2","author":"Stenger","year":"1999","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB26","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0264-410X(97)00109-6","article-title":"CTL induction using synthetic peptides delivered in emulsions-critical role of the formulation procedure","volume":"15","author":"Singh","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.10.016_BIB27","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1128\/IAI.62.6.2536-2544.1994","article-title":"Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins","volume":"62","author":"Andersen","year":"1994","journal-title":"Infect. Immunol."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB28","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1128\/IAI.60.11.4781-4792.1992","article-title":"Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis","volume":"60","author":"Pal","year":"1992","journal-title":"Infect. Immunol."},{"key":"10.1016\/j.vaccine.2003.10.016_BIB29","first-page":"502","article-title":"Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis","volume":"85","author":"Roberts","year":"1995","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2003.10.016_BIB30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0264-410X(93)90190-9","article-title":"Adjuvants\u2014a balance between toxicity and adjuvanticity","volume":"11","author":"Gupta","year":"1993","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03007576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03007576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T13:51:15Z","timestamp":1682603475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03007576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":30,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0264410X03007576"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.10.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}